ScinoPharm Taiwan, Ltd. announced that Chih-Hui Lin, Senior Director of Accounting and Acting Spokesperson and Financial & Accounting Officer and Acting Spokesperson of the company has been replaced by Chih-Ching Hsu, Senior Director of Finance, Head of Corporate Approval, Wholesale and Market Risk Management, HSBC as Financial Officer, effective August 20, 2018.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
28.15 TWD | -1.23% | -1.75% | +6.63% |
05-28 | Scinopharm Taiwan, Ltd. Announces Tenure Expiration of the Company's Compensation Committee | CI |
05-28 | Scinopharm Taiwan, Ltd. Announces Audit Committee Changes | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.63% | 700M | |
+39.22% | 727B | |
+30.57% | 592B | |
-7.85% | 347B | |
+15.48% | 319B | |
-0.12% | 274B | |
+12.55% | 238B | |
+6.65% | 204B | |
-6.09% | 203B | |
-3.37% | 160B |
- Stock Market
- Equities
- 1789 Stock
- News ScinoPharm Taiwan, Ltd.
- ScinoPharm Taiwan, Ltd. Announces Executive Changes, Effective August 20, 2018